Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Biological Therapy × Clear all

Sponsor

Conditions

Myeloproliferative Disorders 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Congenital Abnormalities 1 Carcinoma, Non-Small-Cell Lung 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Paclitaxel 94 Carboplatin 81 Bevacizumab 61 Gemcitabine 35 liposomal doxorubicin 31 pembrolizumab 29 Topotecan 26 Taxes 23 olaparib 22 Immunoglobulin G 17 Disulfides 17 niraparib 16 Docetaxel 16 Cyclophosphamide 16 Cisplatin 14 rucaparib 10 durvalumab 10 Nivolumab 10 Doxorubicin 9 Albumin-Bound Paclitaxel 8 sargramostim 7 pazopanib 7 fludarabine phosphate 7 fludarabine 7 avelumab 7 Ifosfamide 7 epacadostat 6 Trabectedin 6 Sorafenib 6 Magnetic Resonance Spectroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡